In Brief: Abbott Labs/Alcyon Analyzer S.A.
This article was originally published in The Gray Sheet
Executive Summary
Abbott Labs/Alcyon Analyzer S.A.: Abbott enters low-volume clinical chemistry market through Jan. 30 all-cash acquisition of privately held Alcyon, Abbott says. The Saint Mathieu de Treviers, France firm, which will remain a stand-alone subsidiary of Europe-based Abbott Diagnostics, offers a line of three low-volume automated clinical chemistry systems capable of running 160, 300, and 600 tests per hour, respectively. Terms of the deal were not disclosed...